Menu
  • The 5th annual E-Cigarette Summit will take place on Friday 17th November at The Royal Society, London
  • Registration for the E-Cigarette Summit 2017 is now open

Professor Riccardo Polosa

Director
Institute of Internal Medicine and Clinical Immunology, University of Catania

Professor Riccardo Polosa is Director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy.  He is also in charge of the University’s Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK).  He is author of more than 250 peer reviewed articles and books mainly covering repiratory medicine, clinical immunology, and tobacco addiction.  Professor Polosa and his research team have lead several clinical trials on e-cigarettes.

On top of his academic work, he serves also as Chief Scientific Advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League.

CONFLICT OF INTERESTS:

Riccardo Polosa has received lecture fees and research funding from GlaxoSmithKline and Pfizer, manufacturers of stop smoking medications.

He has also served as a consultant for Pfizer and Arbi Group Srl (Milano, Italy), the distributor of Categoria™ e-Cigarettes. His research on electronic cigarettes is currently supported by LIAF (Lega Italiana AntiFumo).

 

Professor Riccardo Polosa will be speaking at:

Panel Discussion and Q&A : Should Nicotine Use Be Accepted in Society – What are the absolute and relative risks?

- 12:35 - 12:55

E-cigarette and harm reversal: evidence for cardio-pulmonary health effects

- 12:15 - 12:35

« Back to previous page